Autor segons l'article: Zamora, A; Ramos, R; Comas-Cufi, M; García-Gil, M; Martí-Lluch, R; Plana, N; Alves-Cabratosa, L; Ponjoan, A; Rodríguez-Borjabad, C; Ibarretxe, D; Roman-Degano, I; Marrugat, J; Elosua, R; Martín-Urda, A; Masana, L
Departament: Medicina i Cirurgia
Autor/s de la URV: Ibarretxe Gerediaga, Daiana / Masana Marín, Luis / Plana Gil, Núria / Rodríguez Borjabad, Cèlia
Paraules clau: Coronary-heart-disease united-states therapy sex-differences primary-care prevalence participants gender disparities adherence
Resum: Familial hypercholesterolemia (FH) is an autosomal dominant disease that has a prevalence of approximately 1/250 inhabitants and is the most frequent cause of early coronary heart disease (CHD). We included 1.343.973 women and 1.210.671 men with at least one LDL-c measurement from the Catalan primary care database. We identified 14.699 subjects with Familial hypercholesterolemia-Phenotype (FH-P) based on LDL-c cut-off points by age (7.033 and 919 women, and 5.088 and 1659 men in primary and secondary prevention, respectively). Lipid lower therapy (LLT), medication possession ratio (MPR) as an indicator of adherence, and number of patients that reached their goal on lipid levels were compared by sex. In primary and secondary prevention, 69% and 54% of women (P = 0.001) and 64% and 51% of men (P = 0.001) were on low-to-moderate-potency LLT. Adherence to LLT was reduced in women older than 55 years, especially in secondary prevention (P = 0.03), where the percentage of women and men with LDL-c > 1.81 mmol/L were 99.9% and 98.9%, respectively (P = 0.001). Women with FH-P are less often treated with high-intensity LLT, less adherent to LLT, and have a lower probability of meeting their LDL-c goals than men, especially in secondary prevention.© 2023. The Author(s).
Àrees temàtiques: Zootecnia / recursos pesqueiros Saúde coletiva Química Psicología Odontología Nutrição Multidisciplinary sciences Multidisciplinary Medicina veterinaria Medicina iii Medicina ii Medicina i Materiais Matemática / probabilidade e estatística Letras / linguística Interdisciplinar Geografía Geociências Farmacia Engenharias iv Engenharias iii Engenharias ii Enfermagem Educação física Educação Economia Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciências agrárias i Ciência de alimentos Ciência da computação Biotecnología Biodiversidade Astronomia / física
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: daiana.ibarretxe@urv.cat luis.masana@urv.cat celia.rodriguez@urv.cat celia.rodriguez@urv.cat
Identificador de l'autor: 0000-0002-0789-4954 0000-0001-8160-3716 0000-0001-8160-3716
Data d'alta del registre: 2024-08-03
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.nature.com/articles/s41598-023-27963-z
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Scientific Reports. 13 (1): 1492-1492
Referència de l'ítem segons les normes APA: Zamora, A; Ramos, R; Comas-Cufi, M; García-Gil, M; Martí-Lluch, R; Plana, N; Alves-Cabratosa, L; Ponjoan, A; Rodríguez-Borjabad, C; Ibarretxe, D; Roma (2023). Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men. Scientific Reports, 13(1), 1492-1492. DOI: 10.1038/s41598-023-27963-z
DOI de l'article: 10.1038/s41598-023-27963-z
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2023
Tipus de publicació: Journal Publications
Repositori URV